BMM-derived CXCL12 leading to cooperativity between CXCR4 and CD44 on the leukemic stem cell in acute myeloid leukemia (AML) and resistance to venetoclax by an increase in expression of CD44 and the embryonic stem cell core transcription factors Sox2, Oct4, and Nanog.